Molecular phenotype of spontaneously arising 4N (G2-tetraploid) intermediates of neoplastic progression in Barrett's esophagus

Cancer Research

Volumn 63, Issue 14, 2003, Pages 4211-4217

  Barrett, Michael T ^a,d   Pritchard, David ^b   Palanca Wessels, Corinna ^c   Anderson, Judy ^c   Reid, Brian J ^a,c   Rabinovitch, Peter S ^a,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b LifeSpan BioSciences   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d AGILENT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CELL CULTURE; CELL CYCLE; CELL IMMORTALIZATION; CELL POPULATION; CHROMOSOME CONDENSATION; DNA MICROARRAY; FLOW CYTOMETRY; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; UNINDEXED SEQUENCE; UPREGULATION;

BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FLOW CYTOMETRY; G2 PHASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLOIDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0041672310     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Shackney, S. E., Smith, C. A., Miller, B. W., Burholt, D. R., Murtha, K., Giles, H. R., Ketterer, D. M., and Pollice, A. A. Model for the genetic evolution of human solid tumors. Cancer Res., 49: 3344-3354, 1989.
2. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Wash. DC), 253: 49-53, 1991.
3. 2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc. Natl. Acad. Sci. USA, 93: 7081-7084, 1996.
4. Blount, P. L., Galipeau, P. C., Sanchez, C. A., Neshat, K., Levine, D. S., Yin, Y., Suzuki, H., Abraham, J. M., Meltzer, S. J., and Reid, B. J. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res., 54: 2292-2295, 1994.
5. Barrett, M. T., Sanchez, C. A., Prevo, L. J., Wong, D. J., Galipeau, P. C., Paulson, T. G., Rabinovitch, P. S., and Reid, B. J. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat. Genet., 22: 106-109, 1999.
6. Rabinovitch, P. S., Longton, G., Blount, P. L., Levine, D. S., and Reid, B. J. Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am. J. Gastroenterol., 96: 3071-3083, 2001.
7. Reid, B. J., Levine, D. S., Longton, G., Blount, P. L., and Rabinovitch, P. S. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am. J. Gastroenterol., 95: 1669-1676, 2000.
8. Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., and Reid, B. J. A p53-dependent mouse spindle checkpoint. Science (Wash. DC), 267: 1353-1356, 1995.
9. Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., and Vande Woude, G. F. Abnormal centrosome amplification in the absence of p53. Science (Wash. DC), 271: 1744-1747, 1996.
10. DiLeonardo, A., Khan, S. H., Linke, S. P., Greco, V., Seidita, G., and Wahl, G. M. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res., 57: 1013-1019, 1997.
11. 1 arrest. Cancer Res., 58: 396-401, 1998.
12. 1. Mol. Biol. Cell, 12: 1315-1328, 2001.
13. Neshat, K., Sanchez, C. A., Galipeau, P. C., Cowan, D. S., Ramel, S., Levine, D. S., and Reid, B. J. Barrett's esophagus: A model of human neoplastic progression. Cold Spring Harbor Symp. on Quant. Biol., 59: 577-583, 1994.
14. Levine, D. S., Blount, P. L., Rudolph, R. E., and Reid, B. J. Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am. J. Gastroenterol., 95: 1152-1157, 2000.
15. Wong, D. J., Paulson, T. G., Prevo, L. J., Galipeau, P. C., Longton, G., Blount, P. L., and Reid, B. J. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res., 61: 8284- 8289, 2001.
16. Prevo, L. J., Sanchez, C. A., Galipeau, P. C., and Reid, B. J. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res., 59: 4784-4787, 1999.
17. Galipeau, P. C., Prevo, L. J., Sanchez, C. A., Longton, G. M., and Reid, B. J. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J. Natl. Cancer Inst. (Bethesda), 91: 2087-2095, 1999.
18. Palanca-Wessels, M. C., Barrett, M. T., Galipeau, P. C., Rohrer, K. L., Reid, B. J., and Rabinovitch, P. S. Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology, 114: 295-304, 1998.
19. Liu, W. M., Mei, R., Bartell, D. M., Di, X., Webster, T. A., and Ryder, T. Rank-based algorithms for analysis of microarrays. Proc. SPIE, 4266: 56-67, 2001.
20. Rabinovitch, P. S., Dziadon, S., Brentnall, T. A., Emond, M. J., Crispin, D. A., Haggitt, R. C., and Bronner, M. P. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res., 59: 5148-5153, 1999.
21. Pines, J., and Rieder, C. L. Re-staging mitosis: a contemporary view of mitotic progression. Nat. Cell Biol., 3: E3-E6, 2001.
22. 2-M transition by p53. Oncogene, 20: 1803-1815, 2001.
23. Karsenti, E., and Vernos, I. Cell cycle - the mitotic spindle: a self-made machine. Science (Wash. DC), 294: 543-547, 2001.
24. Nasmyth, K., Peters, J. M., and Uhlmann, F. Splitting the chromosome: cutting the ties that bind sister chromatids. Science (Wash. DC), 288: 1379-1384, 2000.
25. Zachariae, W., and Nasmyth, K. Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev., 13: 2039-2058, 1999.
26. Page, A. M., and Hieter, P. The anaphase-promoting complex: new subunits and regulators. Annu. Rev. Biochem., 68: 583-609, 1999.
27. Morgan, D. O. Regulation of the APC and the exit from mitosis. Nat. Cell Biol., 1: E47-E53, 1999.
28. Zhou, Y., Gwadry, F. G., Reinhold, W. C., Miller, L. D., Smith, L. H., Scherf, U., Liu, E. T., Kohn, K. W., Pommier, Y., and Weinstein, J. N. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. Cancer Res., 62: 1688-1695, 2002.
29. 1 arrest in resulting tetraploid cells. Cancer Res., 61: 7660-7668, 2001.
30. Cho, R. J., Huang, M. X., Campbell, M. J., Dong, H. L., Steinmetz, L., Sapinoso, L., Hampton, G., Elledge, S. J., Davis, R. W., and Lockhart, D. J. Transcriptional regulation and function during the human cell cycle. Nat. Genet., 27: 48-54, 2001.
31. Nigg, E. A. Mitotic kinases as regulators of ceil division and its checkpoints. Nat. Rev. Mol. Cell. Biol. 2: 21-32, 2001.
32. Hinchcliffe, E. H., and Sluder, G. "It takes two to tango": understanding how centrosome duplication is regulated throughout the cell cycle. Genes Dev., 15: 1167-1181, 2001.
33. Glover, D. M., Hagan, I. M., and Tavares, A. A. M. Polo-like kinases: a team that plays throughout mitosis. Genes Dev., 12: 3777-3787, 1998.
34. Meraldi, P., Lukas, J., Fry, A. M., Bartek, J., and Nigg, E. A. Centrosome duplication in mammalian somafic cells requires E2F and Cdk2-cyclin A. Nat. Cell Biol., 1: 88-93, 1999.
35. Lukas, C., Sorensen, C. S., Kramer, E., Santoni-Rugiu, E., Lindeneg, C., Peters, J. M., Bartek, J., and Lukas, J. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature (Lond.), 401: 815-818, 1999.
36. 2-M checkpoints. Genes Dev., 16: 245-256, 2002.
37. Ranade, K., Hussussian, C. J., Sikorski, R. S., Varmus, H. E., Goldstein, A. M., Tucker, M. A., Serrano, M., Hannon, G. J., Beach, D., and Dracopoli, N. C. Mutations associated with familial melanoma impair p16INK4 function. Nat. Genet., 10: 114-116, 1995.
38. Rayman, J. B., Takahashi, Y., Indjeian, V. B., Dannenberg, J. H., Catchpole, S., Watson, R. J., Riele, H., and Dynlacht, B. D. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev., 16: 933-947, 2002.
39. Zhou, B. B. S., and Elledge, S. J. The DNA damage response: putting checkpoints in perspective. Nature (Lond.), 408: 433-439, 2000.
40. 2-M arrest. Mol. Cell, 7: 293-300, 2001.
41. Paulovich, A. G., Toczyski, D. P., and Hartwell, L. H. When checkpoints fail. Cell, 88: 315-321, 1997.
42. Galgoczy, D. J., and Toczyski, D. P. Checkpoint adaptation precedes spontaneous and damage-induced genomic instability in yeast. Mol. Cell. Biol., 21: 1710-1718, 2001.